| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1784404A4 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 09/09/2009 | EP1781304B1 Use of organic glucosamine salts |
| 09/09/2009 | EP1765370B1 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 09/09/2009 | EP1765290B1 Stabilised supersaturated solid solutions of steroidal drugs |
| 09/09/2009 | EP1732917B8 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 09/09/2009 | EP1728508B1 Medicine for prevention or treatment of frequent urination or urinary incontinence |
| 09/09/2009 | EP1727551B1 Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein |
| 09/09/2009 | EP1723246B1 New expression tools for multiprotein applications |
| 09/09/2009 | EP1681059B1 Pharmaceutical composition containing prostaglandin |
| 09/09/2009 | EP1673359B1 Process for the preparation of crystalline forms of orlistat |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP1664061A4 Process for the synthesis of morphinane compounds and intermediates thereof |
| 09/09/2009 | EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 09/09/2009 | EP1633764B1 Regioselective process for the preparation of o-alkyl macrolide and azalide derivatives |
| 09/09/2009 | EP1610779B1 3-oxo-1,3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
| 09/09/2009 | EP1578342B1 Process for preparation of programmed liberation composition with venlafaxine and the resulting product |
| 09/09/2009 | EP1567477B1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/09/2009 | EP1556398B1 Novel cytarabine monophosphate prodrugs |
| 09/09/2009 | EP1553923B1 Camptothecin-carboxylate formulations |
| 09/09/2009 | EP1539753B1 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | EP1519724B1 Fredericamycin derivatives as medicaments for treating tumours |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1478401B1 Compositions comprising dietary fat complexer and methods for their use |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1458447B1 Combination of cytochome p 450 dependent protease inhibitors |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1432411B1 Timed, sustained release multi-particulate dosage forms of propranolol |
| 09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP1371370B1 Drugs containing reduced vitamin b2 |
| 09/09/2009 | EP1353556A4 Solid- and solution -phase synthesis of heparin and other glycosaminoglycans |
| 09/09/2009 | EP1344527B1 Macrolide antibiotics for endometriosis or uterine myoma |
| 09/09/2009 | EP1305296B1 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP1109562A4 Composite biocidal particles |
| 09/09/2009 | EP1061915A4 Pharmaceutical formulations of taxanes |
| 09/09/2009 | EP1033971B1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | EP0939659B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | CN101528925A Dbait and uses thereof |
| 09/09/2009 | CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 09/09/2009 | CN101528240A Activity enhancer for detoxifying enzyme |
| 09/09/2009 | CN101528239A Ophthalmic aqeous liquid preparation |
| 09/09/2009 | CN101528238A Cardiovascular preparation |
| 09/09/2009 | CN101528237A Elvucitabine pharmaceutical compositions |
| 09/09/2009 | CN101528236A Compositions containing CDP-choline, and methods of use thereof |
| 09/09/2009 | CN101528235A Vegfr3 inhibitors |
| 09/09/2009 | CN101528234A Use of MTKI1 for treating or preventing bone cancer |
| 09/09/2009 | CN101528233A Use of a MT kinase inhibitor for treating or preventing brain cancer |
| 09/09/2009 | CN101528232A Hepatitis C virus inhibitors |
| 09/09/2009 | CN101528231A Methods of using pi3k and mek modulators |
| 09/09/2009 | CN101528230A Indoloquinoline compounds as calcium channel blockers |
| 09/09/2009 | CN101528229A Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 09/09/2009 | CN101528228A Bicyclic heteroaryl inhibitors of PDE4 |
| 09/09/2009 | CN101528227A Azetidinone derivatives and methods of use thereof |
| 09/09/2009 | CN101528226A Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 09/09/2009 | CN101528225A 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 09/09/2009 | CN101528224A Pharmaceutical composition comprising candesartan cilexetil |
| 09/09/2009 | CN101528223A New small molecule inhibitors of MDM2 and the uses thereof |
| 09/09/2009 | CN101528222A Methods and compositions for diagnostic and therapeutic targeting of COX-2 |
| 09/09/2009 | CN101528221A Use of azabicyclo hexane derivatives |
| 09/09/2009 | CN101528220A DMAE as sole agent for the treatment of mild cognitive impairment |
| 09/09/2009 | CN101528219A Lipoxin a4 analogs for the treatment and prevention of intestinal fibrosis |
| 09/09/2009 | CN101528218A Compositions and methods for the treatment of mucositis |
| 09/09/2009 | CN101528217A Ophthalmic compositions comprising diglycine |
| 09/09/2009 | CN101528216A Formulations and methods for treating amyloidosis |
| 09/09/2009 | CN101528215A Compositions of chk1 inhibitors and cyclodextrin |
| 09/09/2009 | CN101528214A Substituted acylanilides and methods of use thereof |
| 09/09/2009 | CN101528213A Combination of modafinil and an antagonist or inverse agonist of the H3 receptor |
| 09/09/2009 | CN101528212A Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitor chelate complexes |
| 09/09/2009 | CN101528211A Ophthalmic percutaneous absorption type preparation |
| 09/09/2009 | CN101528210A Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds |
| 09/09/2009 | CN101528209A Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(MCI), and improvement of cognitive function |
| 09/09/2009 | CN101528208A Compositions and methods for treating or preventing glaucoma or progression thereof |
| 09/09/2009 | CN101525391A Method for extracting amylase from liquorice and application thereof |
| 09/09/2009 | CN101525390A Kappa-carrageenin oligose selenizing derivate, preparation method thereof and application for being used as medicine |
| 09/09/2009 | CN101525366A 3-(2-carboxylbenzoyl)-oleanolic acid, pharmaceutical composition of same and application of same in treating diabetes and/or obesity |
| 09/09/2009 | CN101525364A Crystal form of fulvestrant and preparation method thereof |
| 09/09/2009 | CN101525360A Hydrates of macrolides organic acid salts, preparation and application thereof |
| 09/09/2009 | CN101525342A Surface self-assembly gold nanoprobe with free radical capture performance and preparing method and application thereof |
| 09/09/2009 | CN101525339A Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 09/09/2009 | CN101525336A Carbapenem compound containing substituted formohydrazide group |
| 09/09/2009 | CN101525323A Novel styryl chromone type compound and preparation method and use thereof |
| 09/09/2009 | CN101525319A Febuxostat and drug combination thereof |
| 09/09/2009 | CN101525316A Quinoline derivatives, preparation method and applications thereof |
| 09/09/2009 | CN101525314A Dihydropyridine calcium antagonist compound, preparation method and medicinal application thereof |
| 09/09/2009 | CN101525076A Solid material drinking device |
| 09/09/2009 | CN101524546A Conjugate conjugated from polyethylene glycol and curcumin derivative |
| 09/09/2009 | CN101524545A Hemostatic gel suppository |
| 09/09/2009 | CN101524531A Preparation and application of pharmaceutical composition containing collagen and isosorbide mononitrate |
| 09/09/2009 | CN101524523A External traditional Chinese medicine powder for curing psoriasis |
| 09/09/2009 | CN101524522A Traditional Chinese medicine for curing irregular menstruation |
| 09/09/2009 | CN101524517A Compound Chinese and western medicine for treating upper respiratory tract infection |
| 09/09/2009 | CN101524504A Plaster for treating cervical vertebra and lumbar intervertebral disc protrusion and preparation method thereof |